DK104409C - Fremgangsmåde til fremstilling af quinazolonderivater eller syreadditionssalte deraf. - Google Patents
Fremgangsmåde til fremstilling af quinazolonderivater eller syreadditionssalte deraf.Info
- Publication number
- DK104409C DK104409C DK245564AA DK245564A DK104409C DK 104409 C DK104409 C DK 104409C DK 245564A A DK245564A A DK 245564AA DK 245564 A DK245564 A DK 245564A DK 104409 C DK104409 C DK 104409C
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- acid addition
- addition salts
- quinazolone derivatives
- quinazolone
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEF39784A DE1231705B (de) | 1963-05-18 | 1963-05-18 | Verfahren zur Herstellung von 2, 3-substituierten Chinazolon-(4)-derivaten |
| DEF0042147 | 1964-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK104409C true DK104409C (da) | 1966-05-16 |
Family
ID=25975761
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK245564AA DK104409C (da) | 1963-05-18 | 1964-05-15 | Fremgangsmåde til fremstilling af quinazolonderivater eller syreadditionssalte deraf. |
| DK531164AA DK106039C (da) | 1963-05-18 | 1964-05-15 | Fremgangsmåde til fremstilling af quinazolon-derivater eller syreadditionssalte deraf. |
| DK531064AA DK105765C (da) | 1963-05-18 | 1964-05-15 | Fremgangsmåde til fremstilling af quinazolon-derivater eller syreadditionssalte deraf. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK531164AA DK106039C (da) | 1963-05-18 | 1964-05-15 | Fremgangsmåde til fremstilling af quinazolon-derivater eller syreadditionssalte deraf. |
| DK531064AA DK105765C (da) | 1963-05-18 | 1964-05-15 | Fremgangsmåde til fremstilling af quinazolon-derivater eller syreadditionssalte deraf. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3322756A (cg-RX-API-DMAC7.html) |
| AT (3) | AT258918B (cg-RX-API-DMAC7.html) |
| BE (1) | BE648093A (cg-RX-API-DMAC7.html) |
| CH (3) | CH447182A (cg-RX-API-DMAC7.html) |
| DE (2) | DE1231705B (cg-RX-API-DMAC7.html) |
| DK (3) | DK104409C (cg-RX-API-DMAC7.html) |
| FR (1) | FR3806M (cg-RX-API-DMAC7.html) |
| GB (1) | GB1053063A (cg-RX-API-DMAC7.html) |
| NL (1) | NL6405448A (cg-RX-API-DMAC7.html) |
| SE (3) | SE314074B (cg-RX-API-DMAC7.html) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1003802A (en) * | 1963-06-04 | 1965-09-08 | Searle & Co | Pyrimidinone derivatives |
| GB1062357A (en) * | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
| DE2027645A1 (de) * | 1970-06-05 | 1971-12-09 | Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz | Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel |
| US3900476A (en) * | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
| US3959279A (en) * | 1974-01-28 | 1976-05-25 | Sandoz, Inc. | 1-Substituted-2-imino-quinazolin-4(1H)ones |
| US3936453A (en) * | 1974-01-28 | 1976-02-03 | Sandoz, Inc. | 1-Substituted-2-disubstituted aminoquin azolin-4(1h)-ones |
| US4113637A (en) * | 1974-09-10 | 1978-09-12 | Institut Francais Du Petrole | Alkyl-guanidino-heterocyclic compounds, their manufacture and use as additives for fuels and lubricants |
| GB8429739D0 (en) * | 1984-11-24 | 1985-01-03 | Fbc Ltd | Fungicides |
| US5756502A (en) * | 1994-08-08 | 1998-05-26 | Warner-Lambert Company | Quinazolinone derivatives as cholyecystokinin (CCK) ligands |
| AU4858596A (en) * | 1995-09-15 | 1997-04-01 | Torrey Pines Institute For Molecular Studies | Synthesis of quinazolinone libraries |
| US6258819B1 (en) * | 1999-08-05 | 2001-07-10 | Syntex (U.S.A.) Llc | Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones |
| US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
| US7671200B2 (en) * | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
| US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
| SI3029041T1 (sl) * | 2000-04-25 | 2020-08-31 | Icos Corporation | Inhibitorji humane delta fosfatidil-inozitol 3-kinaze |
| US6667300B2 (en) | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
| WO2002094790A1 (en) * | 2001-05-23 | 2002-11-28 | Mitsubishi Pharma Corporation | Fused heterocyclic compound and medicinal use thereof |
| EP1444209A4 (en) | 2001-11-07 | 2005-02-16 | Merck & Co Inc | INHIBITORS OF MITOTIC KINESINS |
| WO2003043995A1 (en) * | 2001-11-20 | 2003-05-30 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
| EP1480980A4 (en) * | 2002-02-15 | 2005-04-20 | Cytokinetics Inc | SYNTHESIS OF QUINAZOLINONES |
| JP2005530785A (ja) | 2002-05-09 | 2005-10-13 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、及び方法 |
| EP1503993A4 (en) * | 2002-05-09 | 2006-05-03 | Cytokinetics Inc | COMPOUNDS, METHODS AND COMPOSITIONS |
| US7038048B2 (en) * | 2002-05-23 | 2006-05-02 | Cytokinetics, Inc. | 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use |
| JP2005538062A (ja) * | 2002-06-14 | 2005-12-15 | サイトキネティクス・インコーポレーテッド | 化合物、組成物、および方法 |
| EP1537089A4 (en) * | 2002-07-23 | 2008-04-16 | Cytokinetics Inc | CONNECTIONS, COMPOSITIONS AND PROCEDURES |
| JP2005536553A (ja) * | 2002-08-21 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
| AU2003277079A1 (en) * | 2002-09-30 | 2004-05-04 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| US7550590B2 (en) | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| KR20060041309A (ko) * | 2003-08-13 | 2006-05-11 | 다케다 야쿠힌 고교 가부시키가이샤 | ４-피리미돈 유도체 및 펩티딜 펩티다제 저해제로서의 그의용도 |
| US20050043239A1 (en) * | 2003-08-14 | 2005-02-24 | Jason Douangpanya | Methods of inhibiting immune responses stimulated by an endogenous factor |
| US20050054614A1 (en) * | 2003-08-14 | 2005-03-10 | Diacovo Thomas G. | Methods of inhibiting leukocyte accumulation |
| JP2007513058A (ja) * | 2003-09-08 | 2007-05-24 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
| WO2005026148A1 (en) * | 2003-09-08 | 2005-03-24 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| EP1682534A2 (en) * | 2003-11-03 | 2006-07-26 | Cytokinetics, Inc. | Pyrimidin-4-one compounds, compositions, and methods |
| JP2007510660A (ja) * | 2003-11-07 | 2007-04-26 | サイトキネティクス・インコーポレーテッド | 化合物、組成物及び方法 |
| WO2005061460A1 (en) * | 2003-12-08 | 2005-07-07 | Cytokinetics, Inc. | Compounds, compositions, and methods |
| CN102134230B (zh) * | 2004-03-15 | 2019-06-28 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
| WO2005113556A1 (en) | 2004-05-13 | 2005-12-01 | Icos Corporation | Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| WO2005117889A1 (en) * | 2004-05-25 | 2005-12-15 | Icos Corporation | Methods for treating and/or preventing aberrant proliferation of hematopoietic |
| EP1828192B1 (en) | 2004-12-21 | 2014-12-03 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US20080287469A1 (en) * | 2005-02-17 | 2008-11-20 | Diacovo Thomas G | Phosphoinositide 3-Kinase Inhibitors for Inhibiting Leukocyte Accumulation |
| DE102005024017A1 (de) * | 2005-05-25 | 2006-11-30 | Merck Patent Gmbh | Chinazolinone |
| WO2007033265A1 (en) * | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetis |
| ATE532518T1 (de) | 2005-09-14 | 2011-11-15 | Takeda Pharmaceutical | Dipeptidyl-peptidase-hemmer zur behandlung von diabetes |
| CA2622642C (en) * | 2005-09-16 | 2013-12-31 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US8349850B2 (en) * | 2006-03-28 | 2013-01-08 | Atir Holding S.A. | Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| WO2007112368A1 (en) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Preparation of (r)-3-aminopiperidine dihydrochloride |
| US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
| SI2073810T1 (sl) * | 2006-09-13 | 2011-12-30 | Takeda Pharmaceutical | Uporaba 2-6(3-amino-piperidin-1-il)-3-metil-2,4-diokso-3,4-dihidro-2H-pirimidin -1-ilmetil-4-fluoro-benzonitrila za zdravljenje diabetesa, raka, avtoimunskih motenj in infekcije s HIV |
| TW200838536A (en) * | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
| US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
| EP2355828B1 (en) | 2008-11-13 | 2018-05-30 | Gilead Calistoga LLC | Therapies for hematologic malignancies |
| US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
| EP2411391A1 (en) | 2009-03-24 | 2012-02-01 | Gilead Calistoga LLC | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
| CA2759724A1 (en) * | 2009-04-20 | 2010-10-28 | Calistoga Pharmaceuticals, Inc. | Methods of treatment for solid tumors |
| US8691829B2 (en) | 2009-07-21 | 2014-04-08 | Gilead Calistoga Llc | Treatment of liver disorders with PI3K inhibitors |
| EP3581567A1 (en) | 2011-04-10 | 2019-12-18 | Atir Holding S.A. | Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| EA201691327A1 (ru) | 2012-03-05 | 2017-03-31 | Джилид Калистога Ллс | Полиморфные формы (s)-2-(1-(9h-пурин-6-иламино)пропил)-5-фтор-3-фенилхиназолин-4(3h)-она |
| JP2017500319A (ja) | 2013-12-20 | 2017-01-05 | ギリアード カリストガ エルエルシー | （ｓ）−２−（１−（９ｈ−プリン−６−イルアミノ）プロピル）−５−フルオロ−３−フェニルキナゾリン−４（３ｈ）−オンの塩酸塩の多形形態 |
| KR20160095161A (ko) | 2013-12-20 | 2016-08-10 | 길리아드 칼리스토가 엘엘씨 | 포스파티딜이노시톨 3-키나제 억제제의 가공 방법 |
| AU2015274696B2 (en) | 2014-06-13 | 2018-09-27 | Gilead Sciences, Inc. | Phosphatidylinositol 3-kinase inhibitors |
-
0
- GB GB1053063D patent/GB1053063A/en active Active
- DE DENDAT1249281D patent/DE1249281B/de active Pending
-
1963
- 1963-05-18 DE DEF39784A patent/DE1231705B/de active Pending
-
1964
- 1964-05-14 CH CH90467A patent/CH447182A/de unknown
- 1964-05-14 SE SE5933/64A patent/SE314074B/xx unknown
- 1964-05-14 CH CH90567A patent/CH447183A/de unknown
- 1964-05-14 CH CH628164A patent/CH447181A/de unknown
- 1964-05-14 US US367568A patent/US3322756A/en not_active Expired - Lifetime
- 1964-05-15 NL NL6405448A patent/NL6405448A/xx unknown
- 1964-05-15 AT AT774665A patent/AT258918B/de active
- 1964-05-15 DK DK245564AA patent/DK104409C/da active
- 1964-05-15 AT AT774565A patent/AT258917B/de active
- 1964-05-15 AT AT427764A patent/AT254193B/de active
- 1964-05-15 DK DK531164AA patent/DK106039C/da active
- 1964-05-15 DK DK531064AA patent/DK105765C/da active
- 1964-05-19 BE BE648093A patent/BE648093A/xx unknown
- 1964-08-17 FR FR985329A patent/FR3806M/fr active Active
-
1965
- 1965-11-23 SE SE1512665A patent/SE314076B/xx unknown
- 1965-11-23 SE SE1512565A patent/SE314075B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE314075B (cg-RX-API-DMAC7.html) | 1969-09-01 |
| BE648093A (cg-RX-API-DMAC7.html) | 1964-11-19 |
| FR3806M (fr) | 1966-01-03 |
| NL6405448A (cg-RX-API-DMAC7.html) | 1964-11-19 |
| CH447181A (de) | 1967-11-30 |
| AT258918B (de) | 1967-12-27 |
| US3322756A (en) | 1967-05-30 |
| GB1053063A (cg-RX-API-DMAC7.html) | |
| DE1231705B (de) | 1967-01-05 |
| DE1249281B (cg-RX-API-DMAC7.html) | |
| SE314076B (cg-RX-API-DMAC7.html) | 1969-09-01 |
| SE314074B (cg-RX-API-DMAC7.html) | 1969-09-01 |
| CH447182A (de) | 1967-11-30 |
| CH447183A (de) | 1967-11-30 |
| AT254193B (de) | 1967-05-10 |
| AT258917B (de) | 1967-12-27 |
| DK105765C (da) | 1966-11-07 |
| DK106039C (da) | 1966-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK106039C (da) | Fremgangsmåde til fremstilling af quinazolon-derivater eller syreadditionssalte deraf. | |
| DK108972C (da) | Fremgangsmåde til fremstilling af lipoylpyridoxamin eller syreadditionssalte deraf. | |
| DK125421B (da) | Analogifremgangsmåde til fremstilling af 5-substituerede-aza-dibenzo-cycloheptener eller syreadditionssalte deraf. | |
| DK106733C (da) | Fremgangsmåde til fremstilling af 3-hydroxy-5-aminomethyl-isoxazol eller syreadditionssalte deraf. | |
| DK109897C (da) | Fremgangsmåde til fremstilling af bis-alkanolaminderivater eller deres syreadditionssalte. | |
| DK116362B (da) | Fremgangsmåde til fremstilling af basisk substituerede benzothiazepinderivater eller syreadditionssalte deraf. | |
| DK116000B (da) | Fremgangsmåde til fremstilling af amino-halogen-benzylaminer eller syreadditionssalte heraf. | |
| DK119059B (da) | Fremgangsmåde til fremstilling af 2-nitro-imidazolderivater eller syreadditionssalte deraf. | |
| DK129924B (da) | Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf. | |
| DK117636B (da) | Fremgangsmåde til fremstilling af diazocin- eller diazecinderivater eller syreadditionssalte deraf. | |
| DK109142C (da) | Fremgangsmåde til fremstilling af 4-aminoquinolinderivater eller syreadditionssalte deraf. | |
| DK103831C (da) | Fremgangsmåde til fremstilling af 4-azathioxanthenderivater eller syreadditionssalte deraf. | |
| DK106335C (da) | Fremgangsmåde til fremstilling af derivater af 16-hydroxymethylenyohimbanforbindelser eller syreadditionssalte deraf. | |
| DK114485B (da) | Fremgangsmåde fremstilling af imidazolderivater eller syreadditionssalte deraf. | |
| DK112029B (da) | Fremgangsmåde til fremstilling af basiske ethano-anthracenderivater eller syreadditionssalte deraf. | |
| DK108394C (da) | Fremgangsmåde til fremstilling af substituerede imidazo- eller pyrimido-quinazoliner eller syreadditionssalte deraf. | |
| DK121604B (da) | Fremgangsmåde til fremstilling af substituerede iminocycloheptatrienderivater eller syreadditionssalte heraf. | |
| DK107098C (da) | Fremgangsmåde til fremstilling af 5-hydrazino-pyrazol-derivater eller syreadditionssalte deraf. | |
| DK105649C (da) | Fremgangsmåde til fremstilling af 2-dimethylaminopyrazin eller syreadditionssalte deraf. | |
| DK111893B (da) | Fremgangsmåde til fremstilling af substituerede methylhydraziner eller syreadditionssalte deraf. | |
| DK112171B (da) | Fremgangsmåde til fremstilling af benzimidazoler eller syreadditionssalte deraf. | |
| DK116211B (da) | Fremgangsmåde til fremstilling af acridanderivater eller syreadditionssalte deraf. | |
| DK122877B (da) | Analogifremgangsmåde til fremstilling af fenylisopropylalkylaminderivater eller syreadditionssalte deraf. | |
| DK107748C (da) | Fremgangsmåde til fremstilling af 5-nitropyrrolderivater eller syreadditionssalte deraf. | |
| DK105764C (da) | Fremgangsmåde til fremstilling af 1-azathioxanthenderivater eller syreadditionssalte deraf. |